정형외과용 성체 중간엽 줄기세포 시장 : 유래별, 용도별, 최종사용자별, 지역별

Adult Mesenchymal Stem Cells for Orthopedics Market is estimated to be valued at USD 195.0 Mn in 2026 and is expected to reach USD 382.3 Mn by 2033, growing at a compound annual growth rate (CAGR) of 10.1% from 2026 to 2033.

Adult mesenchymal stem cells are multipotent mesenchymal cells with the potential to differentiate into osteoblasts, chondrocytes and adipocytes, therefore are most suitable for use in the orthopedic regenerative field. Sourced from bone marrow, adipose tissue, umbilical cord blood and synovial fluid, they are being employed for a number of musculoskeletal injuries and disorders, including osteoarthritis, articular cartilage defects, bone fracture, tendon injuries and spinal degenerative disease.

The global market for adult mesenchymal stem cells for orthopedics is predicted to be a rapidly growing field due to the increased incidence of orthopedic disorders and age-related conditions, as well as the advancement of regenerative medicine. The rise in clinical evidence for safe and efficacious mesenchymal stem cells therapy, along with an increase in investment from biotechnological firms, pharmaceutical companies and research establishments, is leading to the global application of minimally invasive cell treatments.

Market Dynamics

The global adult mesenchymal stem cells for orthopedics market are driven by increasing incidences of musculoskeletal disorders and orthopedics diseases like osteoarthritis, the growing aging population and high demand for regenerative therapeutic options. The market will also grow due to the development in stem cell isolation, manufacturing and delivery technology, increasing number of clinical trials and favorable regulatory support in developed markets.

However, a number of constraints are present in the market, such as high treatment and manufacturing costs, complex regulatory pathways, and limited long-term clinical evidence. Nevertheless, emergence of allogeneic off-the-shelf MSC products, innovations in tissue engineering and scaffold-based therapies, and increasing investments through industry-academia collaborations will offer new opportunities for growth in adult mesenchymal stem cells for orthopedics market.

Key Features of the Study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global adult mesenchymal stem cells for orthopedics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Mesoblast Limited, Vericel Corporation, MEDIPOST, Anterogen Co., Ltd., TiGenix NV, Thermo Fisher Scientific Inc., Lonza Group AG, STEMCELL Technologies Canada Inc., PromoCell GmbH, and Stemedica Cell Technologies, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global adult mesenchymal stem cells for orthopedics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global adult mesenchymal stem cells for orthopedics market

Market Segmentation

• Source Insights (Revenue, USD Mn, 2021 - 2033)
• Bone Marrow
• Adipose Tissue
• Application Insights (Revenue, USD Mn, 2021 - 2033)
• Knee Injuries
• Shoulder Injuries
• Ankle Injuries
• Foot Injuries
• Back and Spine Injuries
• Others
• End User Insights (Revenue, USD Mn, 2021 - 2033)
• Hospitals
• Specialty Clinics
• Academic and Research Institutions
• Others
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
• Mesoblast Limited
• Vericel Corporation
• MEDIPOST
• Anterogen Co., Ltd.
• TiGenix NV
• Thermo Fisher Scientific Inc.
• Lonza Group AG
• STEMCELL Technologies Canada Inc.
• PromoCell GmbH
• Stemedica Cell Technologies, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Adult Mesenchymal Stem Cells for Orthopedics Market, By Source
  • Global Adult Mesenchymal Stem Cells for Orthopedics Market, By Application
  • Global Adult Mesenchymal Stem Cells for Orthopedics Market, By End User
  • Global Adult Mesenchymal Stem Cells for Orthopedics Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Market Opportunities
• Regulatory Scenario
• Industry Trends

4. Global Adult Mesenchymal Stem Cells for Orthopedics Market, By Source, 2021-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Bone Marrow
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Adipose Tissue
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Adult Mesenchymal Stem Cells for Orthopedics Market, By Application, 2021-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Knee Injuries
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Shoulder Injuries
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Ankle Injuries
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Foot Injuries
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Back and Spine Injuries
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Adult Mesenchymal Stem Cells for Orthopedics Market, By End User, 2021-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Academic and Research Institutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Adult Mesenchymal Stem Cells for Orthopedics Market, By Region, 2021 - 2033, Value (USD Mn)

• Introduction
  • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
  • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Source, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Source, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Source, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Source, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Source, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Source, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Company Profile
  • Mesoblast Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Vericel Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • MEDIPOST
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Anterogen Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • TiGenix NV
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lonza Group AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • STEMCELL Technologies Canada Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PromoCell GmbH
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Stemedica Cell Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us